Cargando…
Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829030/ https://www.ncbi.nlm.nih.gov/pubmed/36695703 http://dx.doi.org/10.1016/j.ajt.2022.11.021 |
| _version_ | 1784867391044321280 |
|---|---|
| author | Riggs, Julie M. Charya, Ananth V. Eberlein, Michael H. Reed, Robert M. Saharia, Kapil K. |
| author_facet | Riggs, Julie M. Charya, Ananth V. Eberlein, Michael H. Reed, Robert M. Saharia, Kapil K. |
| author_sort | Riggs, Julie M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9829030 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98290302023-01-10 Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect Riggs, Julie M. Charya, Ananth V. Eberlein, Michael H. Reed, Robert M. Saharia, Kapil K. Am J Transplant Letter to the Editor American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2023-03 2023-01-09 /pmc/articles/PMC9829030/ /pubmed/36695703 http://dx.doi.org/10.1016/j.ajt.2022.11.021 Text en © 2022 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Riggs, Julie M. Charya, Ananth V. Eberlein, Michael H. Reed, Robert M. Saharia, Kapil K. Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect |
| title | Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect |
| title_full | Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect |
| title_fullStr | Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect |
| title_full_unstemmed | Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect |
| title_short | Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect |
| title_sort | tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829030/ https://www.ncbi.nlm.nih.gov/pubmed/36695703 http://dx.doi.org/10.1016/j.ajt.2022.11.021 |
| work_keys_str_mv | AT riggsjuliem tixagevimabcilgavimabpreexposureprophylaxisandbreakthroughinfectionriskinvaccinatedsolidorgantransplantrecipientsconcernforimmortaltimebiaseffect AT charyaananthv tixagevimabcilgavimabpreexposureprophylaxisandbreakthroughinfectionriskinvaccinatedsolidorgantransplantrecipientsconcernforimmortaltimebiaseffect AT eberleinmichaelh tixagevimabcilgavimabpreexposureprophylaxisandbreakthroughinfectionriskinvaccinatedsolidorgantransplantrecipientsconcernforimmortaltimebiaseffect AT reedrobertm tixagevimabcilgavimabpreexposureprophylaxisandbreakthroughinfectionriskinvaccinatedsolidorgantransplantrecipientsconcernforimmortaltimebiaseffect AT sahariakapilk tixagevimabcilgavimabpreexposureprophylaxisandbreakthroughinfectionriskinvaccinatedsolidorgantransplantrecipientsconcernforimmortaltimebiaseffect |